Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis

被引：0
|
作者：
Robyn Bruen
Sean Curley
Sarina Kajani
Daniel Crean
Marcella E. O’Reilly
Margaret B. Lucitt
Catherine G. Godson
Fiona C. McGillicuddy
Orina Belton
机构：
[1] UCD Conway Institute,Diabetes Complications Research Centre, School of Biomolecular and Biomedical Science
[2] University College Dublin,Diabetes Complications Research Centre, School of Medicine
[3] UCD Conway Institute,Diabetes Complications Research Centre, School of Veterinary Medicine
[4] University College Dublin,School of Medicine, Department of Pharmacology and Therapeutics
[5] UCD Conway Institute,undefined
[6] University College Dublin,undefined
[7] Trinity College Dublin,undefined
[8] The University of Dublin,undefined
来源：
Cardiovascular Diabetology | / 16卷
关键词：
MΦ2 macrophages; Monocytes; Anti-inflammatory; Plaque microenvironment; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis
    Bruen, Robyn
    Curley, Sean
    Kajani, Sarina
    Crean, Daniel
    O'Reilly, Marcella E.
    Lucitt, Margaret B.
    Godson, Catherine G.
    McGillicuddy, Fiona C.
    Belton, Orina
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [2] MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE
    BELLOSTA, S
    MAHLEY, RW
    SANAN, DA
    MURATA, J
    NEWLAND, DL
    TAYLOR, JM
    PITAS, RE
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05): : 2170 - 2179
  • [3] Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
    Fazio, S
    Babaev, VR
    Murray, AB
    Hasty, AH
    Carter, KJ
    Gleaves, LA
    Atkinson, JB
    Linton, MF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4647 - 4652
  • [4] Incretins directly suppress the development of macrophage-driven atherosclerosis in apolipoprotein E-null mice
    Hirano, T.
    Nagashima, M.
    Watanabe, T.
    Nohtomi, K.
    Terasaki, M.
    Miyazaki, A.
    DIABETOLOGIA, 2010, 53 : S72 - S72
  • [5] Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
    Proc Natl Acad Sci USA, 9 (4647):
  • [6] A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice
    Xu, Yanyong
    Liu, Hongmei
    Liu, Mengting
    Li, Feifei
    Liu, Liangchen
    Du, Fen
    Fan, Daping
    Yu, Hong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (08): : 3482 - 3492
  • [7] Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice
    Lalla, E
    Lamster, IB
    Hofmann, MA
    Bucciarelli, L
    Jerud, AP
    Tucker, S
    Lu, Y
    Papapanou, PN
    Schmidt, AM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) : 1405 - 1411
  • [8] Hyperinsulinemia Does Not Change Atherosclerosis Development in Apolipoprotein E Null Mice
    Rask-Madsen, Christian
    Buonomo, Erica
    Li, Qian
    Park, Kyoungmin
    Clermont, Allen C.
    Yerokun, Oluwatobi
    Rekhter, Mark
    King, George L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (05) : 1124 - +
  • [9] The differential effect of restraint stress on early markers of atherosclerosis in male and female Apolipoprotein E null mice
    Andersson, Irene Janet
    Sankaralingam, Sowndramalingam
    Davidge, Sandra T.
    FASEB JOURNAL, 2008, 22
  • [10] Xenogenic macrophage immunization reduces atherosclerosis in apolipoprotein E knockout mice
    Yamashita, Tomoya
    Kawashima, Seinosuke
    Hirase, Tetsuaki
    Shinohara, Masakazu
    Takaya, Tomofumi
    Sasaki, Naoto
    Takeda, Masafumi
    Tawa, Hideto
    Inoue, Nobutaka
    Hirata, Ken-ichi
    Yokoyama, Mitsuhiro
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (03): : C865 - C873
12345